Ann: Paradigm delivers IND to US FDA for Pivotal OA Program, page-43

First 43 Last

Share
Profile

Follow
Darksky

142 Posts.

33

27/03/21

17:26

Post #: 52086364
Share

Originally posted by Darksky: ↑

You never go broke taking a profit, I can't remember who gave me that advice but it's good,

But back to the prospect of having a substantial short position in a stock with tremendous potential IMHO.

What kind of a gap up in price might we expect if the IND for Zilusol is approved?!
I have absolutely no idea. But we are talking about a drug that has been test successfully (on evidence provided here) with over 600 SAS patients, has a long safety record in use with animals, has already caught the attention of pharmaceutical companies (again evidence here) and has a very significant market for it's use.

So, say I was running a managed fund I was short 10 million shares and had the financial capacity to run the price up and down and shake the odd loose holder out from time to time to help cover some of my position and make and book profits month by month along the way and meet my trading profit targets for managerment. What would happen if PAR receives early approval for the IND? would the share price gap up at open (remembering the FDA is in America and their announcement may occur in US time) by $2.50 to $3.00, I really don't know, but if you're short 10 million shares that's a $25 to $30 million loss. And then, what if that announcement was quickly followed by a significant deal with big pharma? Again I have absolutely no idea what that would do to the price. But what if it was an additional $5 gap up that's a potential combined loss of $75 to $80 million. Ouch!!!, and if it's an additional $10 gap up that's potentially a total loss of $125 to $130 million on the one position. Now if I was an agressive fund manager without a position in PAR and I could see the large short position and understood all the evidence about the drug, would I/they see that as an apportunity to put a short squeeze into play. I really don't know, I'm not a fund manager.But If that did occur (depending on the size of the fund) that loss could put their fund into the bottom quartile relative to their peers for quite a while. IMHO DYOR. Anyway, lets just say that a squeeze might just put a STOP to their GAME.
imho dyor

Expand

The perfect storm approaches...

a drug that has been test successfully (based on evidence provided here) with over 600 SAS patients, has a long safety record in use with animals, has already caught the attention of pharmaceutical companies (again evidence here) and has a very significant market for it's use...

AND COMPETITION HAS JUST BEEN ELIMINATED!!!

PAR Price at posting: $2.65 Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

ALK

Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26

LAT

Latitude 66 Shares Surge 8900% on Promising Exploration Update

LLC

ACCC raises competition concerns about acquisition of Lendlease projects

XRG

XReality Group wins $800K contract from Aus Government for military and police VR training tech

AS2

Askari sets exploration target of up to 323K ounces Au at Burracoppin

There are more pages in this discussion • 9 more messages in this thread...

First 43 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 29.5¢		Change 0.000(0.00%)		Mkt cap ! $103.1M

Open	High	Low	Value	Volume
29.0¢	29.5¢	27.5¢	$167.1K	590.3K

Buyers (Bids)

No.	Vol.	Price($)
2	24553	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
29.5¢	49999	1

View Market Depth

No.	Vol.	Price($)
2	24553	0.290
2	19000	0.285
3	98766	0.275
5	77259	0.270
1	3770	0.265

Price($)	Vol.	No.
0.295	49999	1
0.300	77492	5
0.305	2600	1
0.310	141764	5
0.315	14044	1

Last trade - 16.10pm 04/07/2024 (20 minute delay)

PAR (ASX) Chart

Ann: Paradigm delivers IND to US FDA for Pivotal OA Program, page-43

Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26

Latitude 66 Shares Surge 8900% on Promising Exploration Update

ACCC raises competition concerns about acquisition of Lendlease projects

XReality Group wins $800K contract from Aus Government for military and police VR training tech

Askari sets exploration target of up to 323K ounces Au at Burracoppin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Paradigm delivers IND to US FDA for Pivotal OA Program, page-43

Top Stories

Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26

Latitude 66 Shares Surge 8900% on Promising Exploration Update

ACCC raises competition concerns about acquisition of Lendlease projects

XReality Group wins $800K contract from Aus Government for military and police VR training tech

Askari sets exploration target of up to 323K ounces Au at Burracoppin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News